UBS AM’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-30,575
| Closed | -$168K | – | 2813 |
|
|
2022
Q1 | $168K | Hold |
30,575
| – | – | ﹤0.01% | 2702 |
|
|
2021
Q4 | $296K | Sell |
30,575
-1,723
| -5% | -$16.7K | ﹤0.01% | 2679 |
|
|
2021
Q3 | $577K | Sell |
32,298
-8,281
| -20% | -$148K | ﹤0.01% | 2440 |
|
|
2021
Q2 | $991K | Buy |
40,579
+15,679
| +63% | +$383K | ﹤0.01% | 2220 |
|
|
2021
Q1 | $660K | Buy |
24,900
+12,900
| +108% | +$342K | ﹤0.01% | 2285 |
|
|
2020
Q4 | $91.1K | Hold |
12,000
| – | – | ﹤0.01% | 2537 |
|
|
2020
Q3 | $60.1K | Sell |
12,000
-9,298
| -44% | -$46.6K | ﹤0.01% | 2476 |
|
|
2020
Q2 | $127K | Buy |
21,298
+10,998
| +107% | +$65.8K | ﹤0.01% | 2439 |
|
|
2020
Q1 | $45.8K | Hold |
10,300
| – | – | ﹤0.01% | 2437 |
|
|
2019
Q4 | $97.9K | Hold |
10,300
| – | – | ﹤0.01% | 2513 |
|
|
2019
Q3 | $80.9K | Hold |
10,300
| – | – | ﹤0.01% | 2685 |
|
|
2019
Q2 | $162K | Buy |
+10,300
| New | +$162K | ﹤0.01% | 2590 |
|